Just as F1 teams rely on real-time data to optimize performance, IoT is enabling life sciences manufacturers to achieve new ...

Biotech reported positive interim data from a mid-stage trial of a treatment for the rare muscle disorder Duchenne muscular ...

An Oakland financier, which sponsored a life sciences-focused blank-check company this summer that grossed $230 million, ...

Utah's life sciences sector is a significant economic powerhouse, but the misguided the Medication Affordability and Patent ...

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company") a clinical-stage biotechnology ...

Wave Life Sciences Ltd. (NASDAQ:WVE) revealed interim data from the ongoing Phase 2 FORWARD-53 study of WVE-N531 for Duchenne ...

Former Fed chairman Alan Greenspan coined the phrase "irrational exuberance" to describe the risk of unduly escalated asset ...

By engaging with some of the most influential executives in the industry and the many organizations that advocate for them, the series will provide valuable perspectives on the evolving landscape of ...

The primary goals of the study are to evaluate the safety and overall response rate in patients who are given RLS-0071.

Projects focus on cancer therapies, robotic clot removal catheters, and mRNA vaccines, among other technologies ...